Products

Data

Feature

Request Demo

Last update 08 May 2025

Tumoral Calcinosis, Normophosphatemic, Familial

Last update 08 May 2025

Basic Info

Synonyms

CALCINOSIS, TUMORAL, WITH NORMOPHOSPHATEMIA, Calcinosis, Tumoral, With Normophosphatemia, Familial normophosphataemic tumoural calcinosis

+ [9]

Introduction-

Clinical Trials associated with Tumoral Calcinosis, Normophosphatemic, Familial

NCT00004358

/ CompletedPhase 2IIT

Phase II Study of Calcitonin for Tumoral Calcinosis

OBJECTIVES: I. Determine whether intermittent, long-term, subcutaneous administration of calcitonin increases phosphaturia, reduces hyperphosphatemia, and increases intact parathyroid hormone levels in patients with tumoral calcinosis.
II. Determine whether calcitonin reduces or prevents tumor recurrence. III. Determine whether hyperphosphatemia abolishes the normal circadian pattern of serum phosphorus.
IV. Determine how repetitive calcitonin administration alters the biochemical markers of bone metabolism in osteopenic patients with tumoral calcinosis.

Start Date01 Nov 1992

Sponsor / Collaborator

National Center for Research Resources

[+1]

100 Clinical Results associated with Tumoral Calcinosis, Normophosphatemic, Familial

100 Translational Medicine associated with Tumoral Calcinosis, Normophosphatemic, Familial

0 Patents (Medical) associated with Tumoral Calcinosis, Normophosphatemic, Familial

291

Literatures (Medical) associated with Tumoral Calcinosis, Normophosphatemic, Familial

28 Mar 2025·Journal of Surgical Case Reports

Idiopathic tumoral calcinosis of the left thigh: a case report

Article

Author: Eldirdiri, Samaual ; Ibrahim, Mohamed Y ; Eldirdiri, Sami ; Abd Allah, Hind M A ; Elbashir, Ibrahim B A ; Aldaw, Nahid F

AbstractIdiopathic tumoral calcinosis is a very rare benign condition characterized by pathological deposition of calcium phosphate crystals into the soft tissues, particularly into the peri-articular regions. This case report narrates the first reported case of idiopathic tumoral calcinosis in Sudan. A 38-year-old Sudanese female from Gadarif presented with a history of progressive enlargement of the left thigh swelling over a period of 1 year, which was painless. Clinical examination revealed a firm and well-circumscribed mass without overlying skin changes. Imaging revealed calcification with a characteristic “chicken wire” pattern in X-rays, and histopathology confirmed lobulated calcium deposits surrounded by fibrous tissue and foreign body giant cell reactions without malignancy. The patient underwent complete surgical excision of the mass under spinal anesthesia, and her recovery was uneventful. This case highlights the need for recognition of idiopathic tumoral calcinosis in the differential diagnosis of soft tissue masses, especially in the region where these are underreported.

01 Jan 2025·Asian Journal of Surgery

Uremic tumoral calcinosis in the sacral spine of a patient on long-term hemodialysis

Letter

Author: Zhang, Yongbo ; Zhang, Liang

01 Jan 2025·Hemodialysis International

Treatment of a patient with inoperable tumoral calcinosis associated with end stage kidney disease: A case report

Article

Author: Claes, Donna J. ; Hooper, David K. ; Couser, Sarah K. ; Huesman, Sydney

AbstractWe describe a case of severe symptomatic tumoral calcinosis in a young man with end stage kidney disease secondary to antineutrophil cytoplasmic antibodies‐associated vasculitis with longstanding hyperphosphatemia and secondary hyperparathyroidism while on several years of peritoneal dialysis. The use of intravenous sodium thiosulfate, optimization of clearance with five times weekly hemodialysis, and intradialytic nutrition were used to treat his inoperable tumoral calcinosis. Over 3 months, he had a remarkable reduction in the size of his calcified masses and associated improvement in pain. He subsequently received a living donor kidney transplant.

Analysis

Perform a panoramic analysis of this field.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

Who we are

Solutions
Plan
Contact us: phs@patsnap.com

What we do

Drug
Clinical Progress
Patent
Literature
Report
News

Tumoral Calcinosis, Normophosphatemic, Familial

Basic Info

Related

Analysis